Prothena Stock Surges After Parkinson’s Drug Misses Primary Endpoint (NASDAQ:PRTA)
This article was written byFollowBrendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis...
Parkinsons
Annovis Bio: A Close Look At Their Parkinson’s Trial Data (NYSE:ANVS)
Jonathan Knowles Annovis Bio's Parkinson's Trial Announcement On Tuesday, July 2, Annovis Bio, Inc. (NYSE:ANVS) announced data from their long-expected...
